Display options
Share it on

Intest Res. 2018 Jul;16(3):409-415. doi: 10.5217/ir.2018.16.3.409. Epub 2018 Jul 27.

The association between new generation oral contraceptive pill and the development of inflammatory bowel diseases.

Intestinal research

Santosh Sanagapalli, Yanna Ko, Viraj Kariyawasam, Siew C Ng, Whitney Tang, Hithanadura Janaka de Silva, Minhu Chen, Kaichun Wu, Satimai Aniwan, Ka Kei Ng, David Ong, Qin Ouyang, Ida Hilmi, Marcellus Simadibrata, Pises Pisespongsa, Saranya Gopikrishna, Rupert W Leong,

Affiliations

  1. Gastroenterology and Liver Services, Concord Repatriation General Hospital, Concord NSW, Australia.
  2. Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, Institute of Digestive Disease, Li Ka Shing Institute of Health Science, Hong Kong, China.
  3. Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka.
  4. The First Affiliated Hospital of Sun Yat Sen University, Guangzhou, China.
  5. Xijing Hospital, Fourth Military Medical University, Xian, China.
  6. King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
  7. Hospital Conde S Januario, Macau, China.
  8. National University Hospital of Singapore, Singapore.
  9. West China Hospital, Sichuan University, Chengdu, China.
  10. University of Malaya Medical Center, Kuala Lumpur, Malaysia.
  11. University of Indonesia, Indonesia.
  12. Maharaj Nakorn Chiangmai Hospital, Chiangmai, Thailand.

PMID: 30090040 PMCID: PMC6077300 DOI: 10.5217/ir.2018.16.3.409

Abstract

BACKGROUND/AIMS: To examine the association between use of oral contraceptive pills (OCPs) and the risk of developing inflammatory bowel diseases (IBD), in a modern cohort.

METHODS: A prospective nested case-control study across sites in the Asia-Pacific region was conducted; involving female IBD cases and asymptomatic controls. Subjects completed a questionnaire addressing questions related to OCP use. Primary outcome was the risk of development of IBD of those exposed to OCP versus non-exposure. Secondary outcomes were development of Crohn's disease (CD) versus ulcerative colitis (UC), and whether age of first use of OCP use may be associated with risk of IBD.

RESULTS: Three hundred and forty-eight female IBD cases (41% CD, median age: 43 years) and 590 female age-matched controls were recruited. No significant association was found between OCP use and the risk of IBD (odds ratio [OR], 1.65; 95% confidence interval, 0.77-3.13;

CONCLUSIONS: In this large cohort of subjects from the Asia-Pacific region, we found a modest but not significantly increased risk of developing IBD amongst OCP users.

Keywords: Contraceptives, oral; Inflammatory bowel diseases

Conflict of interest statement

CONFLICT OF INTEREST: No potential conflict of interest relevant to this article was reported.

References

  1. Clin Gastroenterol Hepatol. 2015 Aug;13(8):1453-63.e1 - PubMed
  2. Drug Saf. 2016 Mar;39(3):193-7 - PubMed
  3. Dig Liver Dis. 2001 Dec;33(9):762-7 - PubMed
  4. Wien Klin Wochenschr. 2015 May;127(9-10):345-54 - PubMed
  5. Aliment Pharmacol Ther. 2005 Aug 15;22(4):309-15 - PubMed
  6. Hum Reprod Update. 2005 Jul-Aug;11(4):411-23 - PubMed
  7. Eur J Gastroenterol Hepatol. 2017 Sep;29(9):1064-1070 - PubMed
  8. BMJ. 2011 Apr 21;342:d2151 - PubMed
  9. J Gastroenterol Hepatol. 2010 Feb;25(2):325-33 - PubMed
  10. Gut. 1995 Nov;37(5):668-73 - PubMed
  11. Epidemiology. 1992 Jul;3(4):374-8 - PubMed
  12. Acta Obstet Gynecol Scand. 2012 Jul;91(7):810-5 - PubMed
  13. J Crohns Colitis. 2013 Feb;7(1):79-88 - PubMed
  14. Am J Physiol Gastrointest Liver Physiol. 2011 Apr;300(4):G621-6 - PubMed
  15. Clin Gastroenterol Hepatol. 2014 Apr;12(4):644-50 - PubMed
  16. J Crohns Colitis. 2008 Jun;2(2):158-61 - PubMed
  17. Inflamm Bowel Dis. 2012 Jun;18(6):1164-76 - PubMed
  18. Gut. 2015 Jul;64(7):1063-71 - PubMed
  19. J Crohns Colitis. 2011 Dec;5(6):577-84 - PubMed
  20. Gastroenterology. 2013 Jul;145(1):158-165.e2 - PubMed
  21. J Clin Gastroenterol. 2007 Mar;41(3):280-4 - PubMed
  22. J Clin Endocrinol Metab. 2005 Jul;90(7):3863-70 - PubMed
  23. Int J Epidemiol. 1998 Jun;27(3):397-404 - PubMed
  24. Mutat Res. 2010 Aug 7;690(1-2):116-22 - PubMed
  25. Gut. 2004 Feb;53(2):246-50 - PubMed
  26. BMJ. 2009 Aug 13;339:b2921 - PubMed
  27. Obstet Gynecol. 2007 Sep;110(3):587-93 - PubMed
  28. Dig Dis Sci. 1991 Aug;36(8):1147-50 - PubMed
  29. Am J Gastroenterol. 2006 May;101(5):993-1002 - PubMed
  30. Gastroenterology. 2016 Jan;150(1):86-95.e3; quiz e13-4 - PubMed
  31. Autoimmun Rev. 2012 May;11(6-7):A460-4 - PubMed
  32. Best Pract Res Clin Endocrinol Metab. 2013 Feb;27(1):3-12 - PubMed
  33. Contraception. 2007 May;75(5):344-54 - PubMed
  34. Inflamm Bowel Dis. 2013 Aug;19(9):1880-8 - PubMed
  35. Aust Prescr. 2015 Feb;38(1):6-11 - PubMed
  36. Hum Reprod. 1999 Jun;14(6):1493-9 - PubMed
  37. Gut. 2013 Aug;62(8):1153-9 - PubMed
  38. J Crohns Colitis. 2008 Jun;2(2):162-9 - PubMed
  39. BMJ. 2011 Apr 21;342:d2139 - PubMed
  40. Am J Gastroenterol. 2008 Sep;103(9):2394-400 - PubMed
  41. Inflamm Bowel Dis. 2006 Oct;12(10):925-33 - PubMed
  42. N Engl J Med. 2009 Nov 19;361(21):2066-78 - PubMed

Publication Types